Observational studyFrontiers in endocrinology2024

Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice.

Paola Pantanetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.